Enrolling by invitationNCT04398901
Neurodevelopmental Outcomes in ZIKV-Exposed Children
Studying Zika virus disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's National Research Institute
- Principal Investigator
- Sarah B Mulkey, MD, PhDChildren's National Research Institute
- Intervention
- Neurodevelopmental assessments(other)
- Enrollment
- 204 enrolled
- Eligibility
- 3-7 years · All sexes
- Timeline
- 2020 – 2025
Study locations (2)
- Children's National Hospital, Washington D.C., District of Columbia, United States
- Biomelab, Barranquilla, Atlántico, Colombia
Collaborators
Thrasher Research Fund · National Institutes of Health (NIH) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04398901 on ClinicalTrials.govOther trials for Zika virus disease
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE3NCT03037164INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted InfectionsCerus Corporation
- RECRUITINGNCT01386424Screening for LID Clinical Studies Unit Healthy Volunteer ProtocolsNational Institute of Allergy and Infectious Diseases (NIAID)